Key Points

  • Legendary investor Michael Burry asserts that major tech firms are stretching the useful life of AI‑infrastructure assets, thereby understating depreciation and inflating earnings by up to US$176 billion between 2026 and 2028.
  • The companies under scrutiny—Meta Platforms, Oracle Corporation, Microsoft Corporation, Amazon.com, Inc. and Alphabet Inc.—are heavily investing in AI hubs and GPUs that may realistically have 2–3‑year lifespans, not the 5–6 years many firms are using.
  • This scrutiny raises broader questions for earnings quality, valuations in the AI infrastructure build‑out, and how investors (including in Israel) should interpret reported profits in a sector where scale, speed and accounting assumptions intersect.
hero

 

The recent commentary from Burry shines a spotlight on the booming AI infrastructure spending by major tech firms and the implications for profit reporting. In a global environment where capital markets are increasingly driven by AI‑hardware roll‑outs, his argument places depreciation policies under the microscope.

Depreciation Assumptions Versus Reality

Burry’s critique centres on the assertion that these hyperscale tech firms are classifying expensive hardware—such as GPUs and networking equipment—as long‑lived assets (five to six years) when many market commentators estimate actual useful lives of two to three years in the AI acceleration era. By extending depreciation periods, firms reduce the non‑cash expense recognised in each period, thereby presenting higher net income in the near‑term. Burry estimates this may translate into an earnings inflation effect of around US$176 billion for the industry from 2026‑28. Whether every firm faces that scale of mis‑statement remains to be seen, but the magnitude underlines the materiality of the risk.

Market Reaction and Macro Implications

The market reaction has been telling: tech stocks exposed to large AI‑capex programmes have shown increased volatility as investor scrutiny intensifies. For Israeli investors, this bears relevance because global tech valuations and supply‑chains (including chip producers and cloud‑service providers) feed into regional exposure. A mis‑aligned depreciation schedule could influence forward‑looking earnings estimates, margin expectations, and ultimately valuations. On the macro side, the AI‑capex boom is already influencing global hardware markets, semiconductor supply constraints and even cross‑border investment flows. Should depreciation norms shift, that could ripple into how asset‑heavy firms (in tech and beyond) model their earnings and capital‑expenditure cycles.

Strategic Implications for Tech Firms and Investors

From a strategic standpoint, tech firms may face pressure to reconcile hardware refresh cycles with accounting policies. If useful lives are cut, non‑cash charges rise, reducing near‑term earnings—potentially complicating communication with investors. For investors, the implication is that reported earnings need closer analysis of underlying assumptions — not just growth in revenue or capex but also the asset‑life and amortisation/depreciation policies. The Israeli market, which often leverages global tech trends and hardware supply chains, might need to factor in second‑order accounting risks when gauging exposure to international tech firms and infrastructure‑plays.

Looking ahead, the key questions to monitor include whether firms revise useful‑life assumptions in upcoming filings, how analysts adjust forecasting models for depreciation, and whether hardware vendors or second‑tier players show signs of shorter refresh cycles in practice. If asset‑life assumptions compress, the impact could reverberate through valuations, earnings quality and investor confidence in the technology sector.


Comparison, examination, and analysis between investment houses

Leave your details, and an expert from our team will get back to you as soon as possible

    * This article, in whole or in part, does not contain any promise of investment returns, nor does it constitute professional advice to make investments in any particular field.

    To read more about the full disclaimer, click here
    SKN | Commercial Vehicle Group Surges After Strong Q4 CY2025 Sales — Is the Truck Supply Chain Reaccelerating?
    • Arik Arkadi Sluzki
    • 7 Min Read
    • ago 2 hours

    SKN | Commercial Vehicle Group Surges After Strong Q4 CY2025 Sales — Is the Truck Supply Chain Reaccelerating? SKN | Commercial Vehicle Group Surges After Strong Q4 CY2025 Sales — Is the Truck Supply Chain Reaccelerating?

      Shares of Commercial Vehicle Group (NASDAQ: CVGI) surged approximately 24.5% after the company reported stronger-than-expected Q4 CY2025 sales, signaling

    • ago 2 hours
    • 7 Min Read

      Shares of Commercial Vehicle Group (NASDAQ: CVGI) surged approximately 24.5% after the company reported stronger-than-expected Q4 CY2025 sales, signaling

    SKN | Coherent (COHR) Stock Climbs as Demand for AI and Optical Semiconductor Technologies Accelerates
    • omer bar
    • 7 Min Read
    • ago 2 hours

    SKN | Coherent (COHR) Stock Climbs as Demand for AI and Optical Semiconductor Technologies Accelerates SKN | Coherent (COHR) Stock Climbs as Demand for AI and Optical Semiconductor Technologies Accelerates

      Shares of Coherent Corp. (NYSE: COHR) traded higher during the latest market session, drawing attention from investors tracking companies

    • ago 2 hours
    • 7 Min Read

      Shares of Coherent Corp. (NYSE: COHR) traded higher during the latest market session, drawing attention from investors tracking companies

    SKN | Enovis Q4 Earnings in Focus: How the Medical Devices Specialist Stacks Up Against Industry Peers
    • Lior mor
    • 7 Min Read
    • ago 2 hours

    SKN | Enovis Q4 Earnings in Focus: How the Medical Devices Specialist Stacks Up Against Industry Peers SKN | Enovis Q4 Earnings in Focus: How the Medical Devices Specialist Stacks Up Against Industry Peers

      The global medical devices and healthcare technology sector remains one of the most resilient segments of the equity market,

    • ago 2 hours
    • 7 Min Read

      The global medical devices and healthcare technology sector remains one of the most resilient segments of the equity market,

    SKN | Oracle Surges After Q1 CY2026 Revenue Beat — Is Cloud Momentum Reshaping the Software Giant’s Growth Story?
    • Ronny Mor
    • 7 Min Read
    • ago 2 hours

    SKN | Oracle Surges After Q1 CY2026 Revenue Beat — Is Cloud Momentum Reshaping the Software Giant’s Growth Story? SKN | Oracle Surges After Q1 CY2026 Revenue Beat — Is Cloud Momentum Reshaping the Software Giant’s Growth Story?

      Shares of Oracle Corporation (NYSE: ORCL) climbed sharply following the company’s Q1 CY2026 earnings release, after the enterprise software

    • ago 2 hours
    • 7 Min Read

      Shares of Oracle Corporation (NYSE: ORCL) climbed sharply following the company’s Q1 CY2026 earnings release, after the enterprise software